I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| macrophage | 16 studies | 33% ± 14% | |
| natural killer cell | 10 studies | 33% ± 14% | |
| monocyte | 10 studies | 29% ± 16% | |
| conventional dendritic cell | 9 studies | 32% ± 13% | |
| smooth muscle cell | 7 studies | 20% ± 3% | |
| fibroblast | 7 studies | 22% ± 5% | |
| non-classical monocyte | 6 studies | 25% ± 8% | |
| CD4-positive, alpha-beta T cell | 6 studies | 25% ± 10% | |
| endothelial cell | 6 studies | 20% ± 3% | |
| T cell | 6 studies | 24% ± 5% | |
| B cell | 5 studies | 28% ± 9% | |
| CD8-positive, alpha-beta T cell | 5 studies | 23% ± 8% | |
| plasma cell | 4 studies | 25% ± 3% | |
| classical monocyte | 4 studies | 21% ± 1% | |
| mature NK T cell | 4 studies | 24% ± 6% | |
| connective tissue cell | 4 studies | 20% ± 4% | |
| dendritic cell | 4 studies | 35% ± 19% | |
| innate lymphoid cell | 3 studies | 29% ± 8% | |
| myeloid cell | 3 studies | 19% ± 2% | |
| intermediate monocyte | 3 studies | 26% ± 4% | |
| pericyte | 3 studies | 30% ± 14% | |
| leukocyte | 3 studies | 35% ± 15% | |
| gamma-delta T cell | 3 studies | 35% ± 15% |
